1. Astellas Pharma Gmbh (8 from 416 patents)

2. Tron—translationale Onkologie An Der Universitátsmedizin Der Johannes Gutenberg—universitÄt Mainz Gemeinnützige Gmbh (5 from 23 patents)

3. Ganymed Pharmaceuticals Ag (3 from 50 patents)

4. Biontech Ag (2 from 36 patents)

5. Tron-translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz (2 from 14 patents)

6. Tron—translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Ggmbh (1 from 15 patents)

7. Tron Translationale Onkologie an Der Universitatsm (1 from 3 patents)

8. Tron—translationale Onkologie An Der Universitat (1 from 3 patents)

9. Tron—translationale Onkologie An Der Universitatsmedizin Der Johannes Gutenberg-Universitat At Mainz Gemeinnutzige Gmbh (1 from 1 patent)

10. Biontech Se (66 patents)

1. 12059464 - Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

2. 11826402 - Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinoma

3. 11795218 - Diagnosis and therapy of cancer involving cancer stem cells

4. 11541127 - Drug conjugates comprising antibodies against claudin 18.2

5. 10946069 - Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

6. 10813996 - Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

7. 10604568 - Diagnosis and therapy of cancer involving cancer stem cells

8. 10314890 - Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

9. 10022444 - Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

10. 9770487 - Combination therapy involving antibodies against Claudin 18.2 for treatment of pancreatic adenocarcinoma

11. 9433675 - Combination therapy involving antibodies against claudin 18.2 for treatment of cancer